1-Year Outcomes of a Multicenter Randomized Controlled Trial of the Ankura II Thoracic Endoprosthesis for the Endovascular Treatment of Stanford Type B Aortic Dissections
BackgroundThe Ankura II Thoracic Stent Graft System (Lifetech, Shenzhen, China) is an evolution of the Ankura stent graft. This study reports one-year outcomes of the Ankura II Thoracic Stent Graft System for endovascular treatment of Stanford type B aortic dissections.MethodsThe Ankura II Thoracic...
主要な著者: | , , , , , , , , , , , , , , , , , , , |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Frontiers Media S.A.
2022-03-01
|
シリーズ: | Frontiers in Cardiovascular Medicine |
主題: | |
オンライン・アクセス: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.805585/full |